Novel antigens used to detect cell-mediated immune responses over time in Mycobacterium avium subsp. paratuberculosis infected cattle by Mikkelsen, Heidi et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Novel antigens used to detect cell-mediated immune responses over time in
Mycobacterium avium subsp. paratuberculosis infected cattle
Melvang, Heidi Mikkelsen; Aagaard, Claus; Nielsen, Søren Saxmose ; Jungersen, Gregers
Publication date:
2009
Link back to DTU Orbit
Citation (APA):
Mikkelsen, H., Aagaard, C., Nielsen, S. S., & Jungersen, G. (2009). Novel antigens used to detect cell-mediated
immune responses over time in Mycobacterium avium subsp. paratuberculosis infected cattle. Poster session
presented at 3rd European Veterinary Immunology Workshop, Berlin, Germany.
Novel antigens used to detect cell-mediated immune responses 
over time in Mycobacterium avium subsp. paratuberculosis
infected cattle
Conclusions
• PPDj stimulations tested 50% and 60% of the animals as test positive at 
the two first samplings, and less than 20% at the third sampling.
• Ag85b (MAP1609)  tested 50% to 60% of the animals positive at all three 
samplings.
• The groups of latency proteins and secreted proteins tested 50% to 60%of 
the animals positive at the last two samplings. 
• ESAT-6 family peptides (MAP160, exsH and esxU)  tested 50% to 60% of 
the animals as positive at the last two samplings and could be promising 
diagnostic candidates.
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Background
Paratuberculosis is a chronic, granulomatous enteric infection in ruminants 
caused by Mycobacterium subsp. avium paratuberculosis (MAP). Early-
stage MAP infection can be detected using diagnostics for cell mediated 
immune responses, e.g. the whole blood interferon gamma (IFN-γ) test. 
Available IFN-γ tests are using purified protein derivatives of MAP (PPDj) 
which are crude products consisting of undefined antigens with possible 
cross reactions toward other environmental bacteria. 
Objective
The objective was to test novel recombinant antigens in the whole blood 
IFN-γ test to determine if some antigens could be excluded or combined in 
an optimized IFN-γ protocol . 
Methods  
Fourteen novel antigens were selected in silico, expressed as recombinants 
in Escherichia coli and the purified products were used for testing.
Blood samples were collected 3 times with 4 and 5 week intervals from the 
same 30 heifers 15-24 months of age in a herd with known MAP infection.
Novel MAP antigens tested in this study. Homologous sequences in
M. tuberculosis and M. bovis genomes and gene names are listed.
IFN-γ test protocol: 
1) Cultivation of whole blood with MAP antigens
Results
Interpretation
Cut-offs used to discriminate test-positives and test-negatives for each 
antigen was based on samples from 60 heifers 15-24 months of age from a 
non-infected herd. 
Samples were excluded if the IFN-γ response to SEB <1500 pg/ml or if IFN-γ
response to PBS > 250 pg/ml. 
2) IFN- γ detection by ELISA
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Future work
Antigens with high MAP specificity will be selected for inclusion in the 
IFN-γ test. The best combination of antigens remains to be investigated. 
